MassDevice.com +5 | The top 5 medtech stories for March 9, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA labels Physio-Control’s Lifepak 1000 recall as Class I The FDA today labeled a select recall of Physio-Control Lifepak 1000 defibrillators over electrical issues as Class I. A Class 1 indication from the federal watchdog indicates “a reasonable probability that use of these products will cause serious adverse health consequences or death,” according to the agency. Read more 4. Bard logs win in long-running stent graft patent spat with Gore A Delaware federal jury awarded a win to C.R. Bard in an ongoing spat with W.L. Gore & Associates over ultra thin stent graft patents. The 8-man jury ruled that Bard’s patent does not infringe on Gore’s patent, and that Gore’s patent is invalid, according to court documents released yesterday.. Read more 3. German court hands down another mixed decision in TAVR spat between Boston Scientific, Edwards Lifesciences A German court issued a mixed decision in the international battle over transcatheter aortic valve replacement patents between Edwards Lifesciences and Boston Scientific, less than a week after a U.K....
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news